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Summary. In this study we assessed the expression and 
localization of the proto-oncogenes c-fos and c-jun in 
normal bone so as to gain more insight into the role of 
these proto-oncogenes in bone tissue. Femurs of 4-week- 
old rats were examined by non-radioactive in situ 
hybridization. cDNA probes for c-fos- and c-jun-labeled 
digoxygenin were produced by Polymerase Chain 
Reaction (PCR). 
C-fos and c-jun exhibited similar distribution in 
growth plate and bone tissue. Expression of c-fos and c- 
jun mRNAs in growth plate was observed in the 
proliferative zone and partly in the upper layer of the 
hypertrophic zone. In spongy bone, high expression of c- 
fos and c-jun mRNAs was observed in the osteoblast 
cytoplasm. However, there was little expression in bone 
lining cells. In the bony trabeculae, slight expression of 
c-fos and c-jun was observed in the premature osteocytes 
situated close to the bone surface, but no expression was 
detected in osteocytes that possessed relatively large 
lacunae in the center of the trabeculae. C-fos and c-jun 
were also slightly expressed in osteoclasts. These data 
strongly suggest that c-fos and c-jun are involved in 
regulating chondrocyte proliferation as immediate early 
genes, and may also be involved in the gene expression 
of bone matrix proteins as transcription factor (M-1)  in 
vivo. In addition, the fact that strong expression was 
observed in osteoblasts but hardly any expression at all 
in bone lining cells seems to suggest that these genes are 
also involved in osteoblast activation. 
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Introduction 
The proto-oncogene c-fos is the cellular homologue 
of v-fos oncogene derived from murine osteosarcoma 
virus (Curran et al., 1982), and c-jun is the cellular 
homologue of the v-jun oncogene derived from avian 
sarcoma virus (Maki et al., 1987). C-fos and c-jun genes 
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are included in the category of immediate early genes, a 
group of genes expressed initially when resting phase 
(GO phase) cells are stimulated by serum or appropriate 
growth factors (Quantin and Breathnack, 1988). And the 
expression of these proto-oncogenes is controlled at 
transcriptional level (Ryseck et al., 1988). The c-fos and 
c-jun gene products form heterodimers via the leucine 
zipper structure, become activator protein-l (AP-l), and 
are known to control transcription by binding to the AP- 
1 site, which is present in the target gene promotor 
region, as a t ransact ing factor (Chiu et al., 1988). 
Furthermore, AP-1 sites are known to be present in the 
promotor region of some bone-specific genes, such as 
type I collagen, alkaline phosphatase, and osteocalcin 
(Monson et al., 1982; Matuura et al., 1990; Owen et al., 
1990). Therefore, the osteoblast phenotype may be 
affected by the expression of c-fos and c-jun via their 
gene products. In fact, in vitro, expression of c-fos and c- 
jun family has been shown to be associated with bone 
maker genes during osteoblast proliferation and 
differentiation (McCabe et al., 1996). Moreover, 
physiological mediators and hormones such as vitamin 
D (Candeliere et al., 1991) and parathyroid hormone 
(Clohisy et al., 1992; Lee et al., 1994) have been shown 
to affect osteoblast phenotype via the expression of c-fos 
and c-jun. Interestingly, the sequence of vitamin D- 
responsive element overlaps AP-lsite in osteocalcin 
gene (Schule et al., 1990). 
With respect to the relationship between c-fos 
expression and bone-forming cells, c-fos is over- 
expressed in murine and human osteosarcoma (Shoen et 
al., 1986; Ruther et al., 1987; Wu et al., 1990) and c-fos 
is expressed in osteoblastic cells in the fracture healing 
process (Ohta et al., 1991). The M-1 site is also present 
in the promotor region of collagenase (MMP-1) and 
stromelysin (MMP-3) (Brenner et al., 1989; Lafyatis et 
al., 1990; Sirum-Conney and Brinckerhoff, 1991), and c- 
fos and c-jun seem to be involved not only in the 
formation of bone matrix, but in the bone and cartilage 
destruction in the pathophysiology of rheumatoid 
arthritis. 
However, an adequate understanding of the 
expression and distribution of c-fos and c-jun in normal 







